Objective Neuroleptic malignant syndrome (NMS) is a potentially fatal, idiosyncratic reaction
to antipsychotics. Due to low incidence of NMS, research on risk factors of mortality …

Objective: To describe patients with neuroleptic malignant syndrome (NMS), to establish
occurrence of NMS, to investigate risk factors of NMS, and to investigate mortality associated …

Background Neuroleptic malignant syndrome (NMS) is a rare and acute adverse drug
reaction associated with antipsychotic therapy. However, few data on the risk and …

Introduction Neuroleptic malignant syndrome (NMS) is a rare, potentially life‐threatening
antipsychotic‐associated disorder that requires an efficient and timely therapy. The aim of …

Objective: To provide an overview of neuroleptic malignant syndrome (NMS) for the general
practitioner with the most up-to-date information on etiology, workup, and management …

The authors review the literature on persistent sequelae of neuroleptic malignant syndrome
(NMS). They highlight the clinical presentations, assessment, and management of persistent …

Objective: The incidence of neuroleptic malignant syndrome (NMS) is not known, but the
frequency of its occurrence with conventional antipsychotic agents has been reported to vary …

Objective: This systematic review and pooled, patient-level analysis of neuroleptic malignant
syndrome (NMS) case reports and series compared NMS characteristics and outcomes …

Objective To investigate the association between neuroleptic malignant syndrome (NMS)
and levels of antipsychotic exposure. Method Electronic health record data systematically …

BackgroundReports of neuroleptic malignant syndrome (NMS) induced by second-
generation antipsychotic drugs highlight a propensity for atypical clinical presentations …